Navigation Links
Lumenis(R) UltraPulse CO2 Laser to be Featured on National Television with Live Pearly Penile Papule (PPP) Procedure
Date:3/10/2009

Dr. William Groff will perform a PPP laser procedure on The Doctors national show, Tuesday, March 10, 2009. Check local listings for airtime.

SANTA CLARA, Calif., March 10 /PRNewswire/ -- Lumenis Ltd., a global developer, manufacturer and seller of laser, light-based and radio-frequency devices for surgical, aesthetic, and ophthalmic applications, announced that its UltraPulse CO2 laser will be featured on The Doctors national television show on Tuesday, March 10, 2009 as part of a live procedure performed by Dr. William Groff, a dermatologist with La Jolla Cosmetic Surgery Centre. Dr. Groff will treat Pearly Penile Papules (PPP), a condition in which small skin tags or domes form on the penis. Pearly Penile Papules (PPP) are very common and affect approximately 25% of men. PPP is not a sexually transmitted disease and is not contagious, however, it can be emotional disturbing and socially embarrassing, leading many men to seek treatment.

The cause of Pearly Penile Papules is unknown, although they are more common in men in their twenties and thirties and in men who are uncircumcised. PPP are often mistaken for genital warts and as a result, can cause stress and embarrassment.

The UltraPulse CO2 laser provides a quick, painless and permanent solution to PPP. The precision of UltraPulse allows exact vaporization of the papules without damaging the normal skin of the penis. There is no scarring and no loss of sensation and the recovery time is about 1 to 2 weeks.

"With more than 18 years of clinical experience, 34 FDA cleared indications and more than 90 peer-reviewed publications, the UltraPulse offers a safe and effective solution to men suffering from this condition," said Mr. Robert Mann, General Manager of Lumenis Global Aesthetics and Dermatology.

"While PPP is not a harmful condition, many men suffer embarrassment and humiliation in silence," said Dr. William Groff. "It is important for men to know that there is a safe, easy and effective solution."

About PPP

Pearly penile papules are small dome-shaped bumps that sometimes appear around the circumference of the penis. These bumps, or papules, are commonly skin-colored. Pearly penile papules, technically called hirsuties papillaris genitalis, are not sexually transmitted. Their cause is unknown, although they are more common in men in their twenties and thirties, and are also more common in uncircumcised males.

Some men choose to leave this condition untreated, as the papules are generally asymptomatic. However, many men find this condition to be embarrassing in intimate situations and suffer detrimental social and emotional effects from leaving the papules untreated.

Treatment for pearly penile papules is typically quite simple and effective through carbon dioxide laser treatment by a qualified dermatologist.

About Lumenis

Lumenis is Israel's largest medical device company with more than 800 employees worldwide. The Company invests heavily in R&D and holds a leading position in the markets in which it serves. Lumenis has over 250 patents worldwide, over 75 FDA clearances, worldwide presence in over 100 countries, and an installed base of over 70,000 systems. For more information about Lumenis and its products, log onto www.lumenis.com.

Lumenis(R) is a registered trademark of Lumenis Ltd.

UltraPulse(R) is a trademark of Lumenis Ltd.

    Contact:
    Michelle Maydan
    Director of Corporate Communications
    1-866-569-0597
    +972-4-959-9004
    e-mail: mmaydan@lumenis.com


'/>"/>
SOURCE Lumenis Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lumenis(R) Introduces LightSheer(R) Duet(TM) for High Speed Permanent Hair Reduction
2. Lumenis(R) Introduces Four New Products & Delivery Devices at the 2008 American Academy of Ophthalmology Annual Meeting in Atlanta, Georgia USA
3. Lumenis(R) Seeks Shareholder Approval of Proposed Class Action Settlement
4. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
5. LCA-Vision New Excimer Laser Strategy to Reduce Operating Expenses in Excess of $3 Million Annually
6. New Laser Combo Therapy Zaps Acne
7. MedX Health Receives CE Mark for Laser & Light Products
8. State of the Art Cornea and Laser Vision Correction Practice Opens in Colorado
9. Acara Launches Laser Lipolysis Business Boosting Program
10. Laser Therapy Disappoints in Stroke Trial
11. Renaissance Laser & Vein Institute (LaserandVeinclinic.com) Provides Top Notch Varicose Vein Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... 2017 , ... An August 3rd article on Reuters covers a new University of ... JAMA (the Journal of the American Medical Association). The study found that a lower percentage ... 30, when compared to patients with lower BMIs. At present, weight loss patients must have ...
(Date:8/16/2017)... ... August 16, 2017 , ... The Data Council, the leading ... was acquired by Advantage Solutions. The Data Council’s IX-ONE platform is the ... industry’s leading suppliers, brokers, distributors and retailers. The Data Council will become a ...
(Date:8/16/2017)... ... August 16, 2017 , ... In ... They celebrate 30 years in business this year, and they’re marking the milestone ... space to serve their patients. , It stands to reason that, given ...
(Date:8/16/2017)... ... August 16, 2017 , ... Modern Consulting Insurance & ... program. Partnering once again with Boys & Girls Clubs of Greater Kansas City, ... area’s very own American Idol. With all proceeds benefitting local worthy causes, donations ...
(Date:8/16/2017)... ... ... Paul Vitenas, MD, FACS , is honored to announce that he ... the nation’s top physicians, in a variety of specialties. This marks the fourth year ... Connolly’s coveted ranking. , Castle Connolly is the nation’s trusted provider of information on ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... , Aug. 2, 2017 ... Who,s Who as a Pinnacle Lifetime Professional in ... Key Account Manager at Turing Pharmaceuticals, AG. Her ... troubleshooting and relationship building.                ... more than 25 years of experience as a ...
(Date:8/1/2017)... 2017   CerSci Therapeutics , a non-opioid drug ... , has received notice from the National Institute on ... (NIH) that it has been awarded a Direct-to-Phase II ... in 2017 with an additional $1,000,000 to follow in ... application of their lead non-opioid drug candidate CT-044 to ...
(Date:7/28/2017)... July 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") ... third quarter ended June 30, 2017, and updated its ... For the fiscal third quarter, Hill-Rom ... $0.68 per diluted share in the prior-year period. These ... $0.39 per diluted share primarily related to the non-cash ...
Breaking Medicine Technology: